Anxo Pharmaceutical Co (ROCO:6677) COGS-to-Revenue : 0.58 (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Anxo Pharmaceutical Co COGS-to-Revenue?

Anxo Pharmaceutical Co's Cost of Goods Sold for the six months ended in Jun. 2023 was NT$256.3 Mil. Its Revenue for the six months ended in Jun. 2023 was NT$445.2 Mil.

Anxo Pharmaceutical Co's COGS to Revenue for the six months ended in Jun. 2023 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Anxo Pharmaceutical Co's Gross Margin % for the six months ended in Jun. 2023 was 42.42%.

Anxo Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Anxo Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anxo Pharmaceutical Co COGS-to-Revenue Chart

Anxo Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.60

0.64

0.59

0.60

0.62

Anxo Pharmaceutical Co Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial												0.61	0.58	0.69	0.57	0.58

Anxo Pharmaceutical Co COGS-to-Revenue Calculation

Anxo Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	534.816	/	866.274
	=	0.62

Anxo Pharmaceutical Co's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	256.328	/	445.186
	=	0.58

Anxo Pharmaceutical Co (ROCO:6677) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Anxo Pharmaceutical Co's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	256.328 / 445.186
	=	42.42 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Anxo Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Anxo Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Anxo Pharmaceutical Co (ROCO:6677) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anxo Pharmaceutical Co Ltd (ROCO:6677) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN

Website

http://www.anxo.com.tw

Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.

Anxo Pharmaceutical Co (ROCO:6677) Headlines

No Headlines